Status:
COMPLETED
Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas
Lead Sponsor:
King Edward Medical University
Conditions:
Comparison of Efficacy of Sclerotherapy in Infantile Hemangioma
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
Objective: This study is intended to compare the outcome of intralesional bleomycin with dexamethasone versus the bleomycin alone in infantile haemangioma. Materials and Methods: This RCT was perfo...
Detailed Description
Introduction: Infantile haemangioma (IH) is a common tumor found in children. The history of this tumor consists of an early phase of growth followed by slow resolution over a period of three to seve...
Eligibility Criteria
Inclusion
- Patients with haemangioma with size equal or more than 1 c
- Less than 12 years and above 1 month of age.
Exclusion
- Patients with previous surgical procedure for haemangiomas
- Patients with chronic respiratory conditions confirmed by history, symptoms and physical examination.
- The diagnosed case of pulmonary fibrosis.
- Patients sensitive to bleomycin proved upon giving a test dose
Key Trial Info
Start Date :
March 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2022
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT06080724
Start Date
March 22 2021
End Date
March 20 2022
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
department of pediatric surgery King Edward Medical University
Lahore, Punjab Province, Pakistan, 54000